Board Members & Key Executives

Mr Bob Moses BA, MBA
Chairman

Founder, Executive, Chairman, CEO of multiple life science companies over the past 40 years. Bob Moses has executive experience with Eli Lilly, ICI Australia, CSL Limited, Freehills, Amrad, Meditech, Daratech, Australian Stem Cell Centre, TGR Biosciences, CRC for Polymers.

Professor Alan Trounson AO MSc, PhD, LLD, FRCOG, FATSE, FAHMS, FRANZCOG
CEO & Executive Director

Stem cell biologist, IVF pioneer & former President of the California Institute for Regenerative Medicine. Alan Trounson is Emeritus Professor Monash University and Distinguished Scientist, Hudson Institute for Medical Research, Clayton, Victoria, Australia.

Dr Colin Lee MBBS, FRCOG, MMED, O&G
Non-Executive Director

Gynaecologist and fertility specialist. Dr. Colin Lee is the founder of TMC Life Sciences Bhd, an IVF company he publicly listed in 2005. He is also the Founder and Medical Director of Alpha International Fertility Centre, Kuala Lumpur.

Professor Bryan R. G. Williams PhD, BSc (Hons), Hon FRSNZ, FAA
Non-Executive Director

Professor Bryan R.G. Williams is an internationally recognised cancer researcher with considerable Board experience, including Pacific Edge Pty Ltd, EngenelC Pty Ltd, MEI Pharma, Cancer Trials Australia, Hope Funds for Cancer Research and BioGrid Australia Ltd.

He is a professor at Monash University and Hudson Institute of Medical Research. Fellow of the Australian Academy of Science and Fellow of the American Academy of Microbiology.

Ms Geraldine (Gerry) Farrell BSc, LLB, LLM, GAICD
Non-Executive Director

Gerry Farrell is an operations executive, general counsel, company secretary and IP & commercial lawyer, with more than 20 years’ experience in the Australian biotechnology industry, having worked with several listed and unlisted companies.

Currently General Counsel, Corporate at Orica Limited, she has held previous positions at Cann Group Limited (medicinal cannabis), Nexvet (now part of Zoetis), leading corporate and IP law firms, and former council member of Swinburne University of Technology.

Mr Henry Kho BCom (Hons)
Non-Executive Director

Co-Founder and retired Executive Director of Perdana Petroleum Berhad listed on Kuala Lumpur Stock Exchange, Malaysia. Henry Kho is experienced in business development, corporate exercise, capital raising, merger and acquisitions.

Mr Jie Xia
Non-Executive Director

Mr Xia Jie is a well-known investor in China’s health and medical industry investment field, currently the Chairman of Shunxi Holdings Group, the Chairman of Shunxi Health Industry Group, and the honorary Chairman of the London Chinatown Chamber of Commerce.

Heather Hawkins
Board Advisor

Heather Hawkins is a woman of two lives – from an everyday mother of two who battled Ovarian Cancer at age 41 with an unknown future, to an international adventurer, stepping into the world of extreme marathons in some of the world’s most inhospitable locations. Heather’s is not just another remarkable and inspiring story, but one that will take you on a personal journey around the world, into the ice and winds of the North Pole and Antarctica, to the sands and scorching heat of the Sahara and Outback Australia and across the majestic roof tops of the Himalayas, Chile and Tanzania.

Professor Alan Trounson AO MSc, PhD, LLD, FRCOG, FATSE, FAHMS, FRANZCOG
CEO & Executive Director

Stem cell biologist, IVF pioneer & former President of the California Institute for Regenerative Medicine. Alan Trounson is Emeritus Professor Monash University and Distinguished Scientist, Hudson Institute for Medical Research, Clayton, Victoria, Australia.

Dr Richard Boyd BSc (Hons), PhD
Chief Scientific Advisor

Professor of Immunology at Monash University, Dr Richard Boyd is an expert in the nature and function of the thymus microenvironment for forming T cells from blood stem cells and pioneer of clinical trials to boost the T cell-based immune system in cancer patients through rejuvenation of the thymus.

Dr Ian Nisbet PhD
Chief Operating Officer

Dr Ian Nisbet is the founder, Executive, Chairman or CEO of multiple life sciences companies, including several in Oncology. He brings over 25 years of direct biotech, strategic and operational experience to the team.

Telma Mantas
Director, IP and Licensing

Telma is the Director of IP and Licensing for Cartherics. She is responsible for managing IP, licensing-in opportunities, and competitive intelligence activities. She has more than 15 years of experience in IP and innovation, having worked as an Intellectual Property Manager, Patent Examiner and Business Consultant in various organisations worldwide.

Jenni Pavlou
People & Culture Manager

As the People & Culture Manager, Jen partners with the business to ensure the end-to-end people practices deliver an excellent people experience; and a culture conducive to achieving the goals of the organisation.

Jen has experience in People & Culture in multiple industries both as an employee and a consultant, and holds a Graduate Diploma of Business in HR and a Bachelor of Education.

Dr Walid J Azar PhD
Acting Chief Scientific Officer

An experienced molecular biologist with an unwavering passion for the development of cancer therapies. With a strong commitment to advancing the field of oncology, Dr. Azar brings extensive experience from a diverse scientific background that spans both academic research and the fast-paced biotechnology industry.

Dr Igor Gonda PhD
Business Manager Autologous Therapies

Dr Igor Gonda is an experienced developer of pharmaceutical products. He has held the position of Chief Executive Officer in public and private pharmaceutical companies in USA and Australia. His earlier career included senior research and development jobs in industry and universities.